Imperial Innovations Group Share News (IVO)

Earnings, Trading Statements Calendar - Week Ahead

Earnings, Trading Statements Calendar - Week Ahead

Earnings, Trading Statements Calendar - Week Ahead

Earnings, Trading Statements Calendar - Week Ahead

Earnings, Trading Statements Calendar - Week Ahead

Earnings, Trading Statements Calendar - Week Ahead

Imperial Innovations portfolio company gets US drug approval

Technology transfer and investment group Imperial Innovations said its portfolio company Cell Medica received an orphan drug designation by the US Food and Drug Administration. The designation for Cell's cancer immunotherapy product CMD-003 means the group now qualifies for seven years of market exc

Imperial Innovations Portfolio Company's Drug Gets Orphan Designation

Imperial Innovations' Cell Medica Begins Manufacturing In Berlin

Imperial Innovations Commits To Veryan Funding Round

Thursday tips round-up: Weir Group, Imperial Innovations

Having failed in its bid to purchase Finnish group Metso Weir Group purchased Trio, a far smaller outfit, marking its first bolt-on acquisition since the start of last year. Trio specialises in comminution, the process by which large rocks are crushed so as to allow miners to get more easily to the

Imperial Innovations Profit Up As Portfolio Boosted By Circassia IPO

Imperial Innovations Invests GBP1.9 Million In Kesios Therapeutics

Woodford reveals top 10 holdings dominated by pharma and tobacco

Highly influential fund manager Neil Woodford has revealed the top 10 stocks in his new £1.6bn Woodford Equity Income fund, including new favourites Imperial Innovations and Rolls-Royce. The university technology spin-out group and the aircraft engine-maker did not feature in the manager's previous

TOP NEWS: Three More Healthcare And Tech Firms Set For London IPO